Zhong YS - Search Results

1

Endoscopic retrograde appendicitis therapy for management of chronic fecalith appendicitis.

Ma LY, Hu JW, Cai XL, Liu ZQ, Zhong YS, Lin SL, Chen TY, Cai SL, Zhang YQ, Chen WF, Ma LL, Cai MY, Qin WZ, Ma X, Li QL, Zhou PH. Ma LY, et al. Among authors: zhong ys. Surg Endosc. 2024 Nov 21. doi: 10.1007/s00464-024-11339-z. Online ahead of print. Surg Endosc. 2024. PMID: 39572426

2

Repeat Peroral Endoscopic Myotomy: Technical Difficulty and Risk Factors.

Ma LY, Guo KY, Liu ZQ, Chen SY, Zhong YS, Zhang YQ, Chen WF, Ma LL, Qin WZ, Hu JW, Cai MY, Yao LQ, Li QL, Zhou PH. Ma LY, et al. Among authors: zhong ys. Gastrointest Endosc. 2024 Nov 16:S0016-5107(24)03729-5. doi: 10.1016/j.gie.2024.11.019. Online ahead of print. Gastrointest Endosc. 2024. PMID: 39557206

3

Association of macular microcirculation with renal function in Chinese non-diabetic patients with hypertension.

Liu XH, Huang QF, Chen YL, Wang XY, Zhong YS, Wang JG. Liu XH, et al. Among authors: zhong ys. Eye (Lond). 2024 Nov 16. doi: 10.1038/s41433-024-03482-7. Online ahead of print. Eye (Lond). 2024. PMID: 39550472

4

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants.

Zhong YS, Kong QH, Wang J, Ye F, Li XY, Zhang LQ, Dai DP, Hu GX, Cai JP, Qian JC, Ji FS. Zhong YS, et al. Chem Res Toxicol. 2024 Nov 18;37(11):1903-1910. doi: 10.1021/acs.chemrestox.4c00298. Epub 2024 Oct 21. Chem Res Toxicol. 2024. PMID: 39433447

5

Activity Variations of CYP2B6 Determine the Metabolic Stratification of Efavirenz.

Li XY, Liu Q, Xu XY, Wang J, Zhong YS, Jin LH, Yuan J, Qian JC, Zhang XD. Li XY, et al. Among authors: zhong ys. Chem Res Toxicol. 2024 Nov 18;37(11):1867-1875. doi: 10.1021/acs.chemrestox.4c00230. Epub 2024 Oct 14. Chem Res Toxicol. 2024. PMID: 39400275

6

[Prevalence of dentinal hypersensitivity and related factors in Chinese urban adults].

Wang ZY, Rong WS, Zhong YS, Tian JG, Chen X, Zhao M, Cui LH, Du MQ, Li JB, Hu DY. Wang ZY, et al. Among authors: zhong ys. Zhonghua Kou Qiang Yi Xue Za Zhi. 2024 Sep 9;59(9):927-934. doi: 10.3760/cma.j.cn112144-20231229-00312. Zhonghua Kou Qiang Yi Xue Za Zhi. 2024. PMID: 39289981 Chinese.

7

New drug combination regimen based on pharmacokinetic characteristics-Erdafitinib combined with sertraline or duloxetine.

Zhang XD, Xu XY, Zhong YS, Zhang ZY, Jin LH, Luo JC, Ye F, Ni JH, Chen J, Chen GZ, Qian JC, Liu ZG. Zhang XD, et al. Among authors: zhong ys. Biomed Pharmacother. 2024 Oct;179:117414. doi: 10.1016/j.biopha.2024.117414. Epub 2024 Sep 10. Biomed Pharmacother. 2024. PMID: 39260324 Free article.

8

Endoscopic resection for calcifying fibrous tumors of the gastrointestinal tract.

Geng ZH, Zhu Y, Fu PY, Qu YF, Chen SY, Zhong YS, Zhang YQ, Chen WF, Qin WZ, Hu JW, Cai MY, Yao LQ, Li QL, Zhou PH. Geng ZH, et al. Among authors: zhong ys. World J Clin Oncol. 2024 Feb 24;15(2):282-289. doi: 10.5306/wjco.v15.i2.282. World J Clin Oncol. 2024. PMID: 38455132 Free PMC article.

9

Postbiotics in colorectal cancer: intervention mechanisms and perspectives.

Xie W, Zhong YS, Li XJ, Kang YK, Peng QY, Ying HZ. Xie W, et al. Among authors: zhong ys. Front Microbiol. 2024 Feb 21;15:1360225. doi: 10.3389/fmicb.2024.1360225. eCollection 2024. Front Microbiol. 2024. PMID: 38450163 Free PMC article. Review.

10

Long-term outcomes of endoscopic resection for well-differentiated nonampullary duodenal neuroendocrine tumors.

Wang Y, Ren Z, Shen YH, Fang XG, Li QL, Zhong YS, Zhang YQ, Chen WF, Zhou PH, Lin SL. Wang Y, et al. Among authors: zhong ys. Gastrointest Endosc. 2024 Sep;100(3):481-491.e6. doi: 10.1016/j.gie.2024.02.017. Epub 2024 Feb 29. Gastrointest Endosc. 2024. PMID: 38431107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters